RMC-4630

CAS No. 2172652-48-9

RMC-4630( SHP2-IN-7 )

Catalog No. M28230 CAS No. 2172652-48-9

RMC-4630 is an inhibitor of SHP2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 358 In Stock
5MG 325 In Stock
10MG 520 In Stock
25MG 851 In Stock
50MG 1135 In Stock
100MG 1535 In Stock
200MG 2065 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RMC-4630
  • Note
    Research use only, not for human use.
  • Brief Description
    RMC-4630 is an inhibitor of SHP2.
  • Description
    RMC-4630 is an inhibitor of SHP2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SHP2-IN-7
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    nAChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2172652-48-9
  • Formula Weight
    450.98
  • Molecular Formula
    C20H27ClN6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (110.87 mM)
  • SMILES
    C[C@@H]1OCC(CC2)(CCN2c(nc2C)c(CO)nc2Sc2ccnc(N)c2Cl)[C@@H]1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Papke RL, et, al. Compositions et methodes d'inhibition selective des recepteurs nicotiniques de l'acetylcholine. WO2005032479A2
molnova catalog
related products
  • [pTyr5] EGFR 988-993

    [pTyr5] EGFR (988-993) is derived from the autophosphorylation site (Tyr992) of epidermal growth factor receptor (EGFR 988-993). [pTyr5] EGFR (988-993) is often complexed with the catalytically inactive protein-tyrosine phosphate 1B (PTP1B).

  • Tegeprotafib

    Tegeprotafib (PTPN2/1-IN-1, Compound 124) is an orally active inhibitor targeting both PTPN2 and PTPN1B, with potent IC50 values of 4.4 nM for PTPN2 and 1-10 nM for PTPN1B, respectively .

  • h-NTPDase8-IN-1

    h-NTPDase8-IN-1 is a specific aminosulfonylbenzamide inhibitor of h-NTPDases8 (IC 50 = 0.28 ± 0.07 μM). h-NTPDase8-IN-1 can be used to study diseases brought about by aberrant h -NTPDase expression.